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Abstract - Best care is not necessarily the 
most expensive, but the most appropriate, 
and prevention is the most powerful tool to 
promote health. A novel approach might 
envision the reduction of hospital 
admittance (thus meeting a requirement 
from long term condition patients: they 
would rather not being hospitalized!) and 
the enforcement of peripheral (both on the 
territory and at home) assistance. In this 
direction, experiences of reshaping new 
service deliveries towards an integrated 
disease management, namely clinical 
pathways, can be observed in Europe and in 
different parts of the world. Aim of this 
paper is to provide a methodological 
guideline to support the management in 
planning clinical pathways, also outlining 
the main barriers limiting the process. In 
particular, we present the results of 
planning a clinical pathway at the Centre 
for Hypertension of the Federico II 
University Hospital (Naples, Italy). The case 
study showed that the introduction of a 
similar service impacts on the organisation 
of the structure. An analysis of 
organizational processes “as are” and the 
re-design of processes “to be” are necessary 
to integrate the clinical pathway into the 
actual activities.  
 
Keywords: Non Communicable chronic 
disease, care pathway, ICT 
I. INTRODUCTION 
The clinical pathway is a specific “package” of 
care instruments enclosing multiple, complex 
and integrated health services. It designs a 
specific process of care and focuses on the best 
management achievable for specific diseases, 
rather than dealing with acute events. 
Therefore, it shifts healthcare systems away 
from the current emphasis on acute care 
towards improved chronic and long-term care, 
in response to the transitions generated by 
epidemiological and demographic change. The 
aim is the “clinical governance” of the patient, 
in order to reduce the progression of chronic 
conditions and enforce their prevention. 
Prevention includes the efforts and actions 
aimed at reducing modern pandemics such as 
obesity, cardiovascular diseases and cancer: 
i.e. the enforcement of healthy lifestyle 
policies about nutrition, physical activity, 
drug, tobacco, sexual health. A consistent and 
growing body of literature describes how 
control and prevention of diseases lead to a 
more efficient use of resources, improves the 
quality of care and the patient outcomes, and 
represent the strength of the clinical pathways.  
In a study about the implementation of 
vascular clinical pathways, Calligaro el al.[1] 
described a reduction in the average length of 
stay of in-patients and, consequently, a 
reduction of costs. Flynn [2] reached the same 
conclusion with a study on the effects of a 
revised clinical pathway on patients admitted 
with total hip fracture. 
Cost reduction in term of reduced use of 
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diagnostic services is the theme tackled by 
Hart [3], Kwan-Gett et al. [4], and Board el al. 
[5].  
Clinical pathways present positive effects 
also on the quality of care and patient 
outcomes as demonstrated in a number of 
studies on different models: Borkowsk [6], in a 
study on hip and knee replacements pathway, 
Chang et al.[7], in a study on pathway for 
radical nephrectomy, and other studies by 
Gretebeck et al.[8], Ibarra et al.[9], Bultema et 
al.[10]. 
The introduction of clinical pathways 
improves the teamwork in term of conflicts 
[11-12], better communication [2], 
improvement of coordination, reduction of 
delays, reduction of misunderstandings and 
duplications when more units are involved, as 
showed in a study on cerebrovascular accident 
[13]. Legal benefits and reduction of 
malpractice claims [14-17] are also positive 
effects of the implementation of the clinical 
pathways.  
Clinical pathways give patients the 
appropriate method of care, fostering and 
improving the understanding among doctors 
and other clinicians about the process of care 
[18]. Although there are several positive 
effects of this kind of service [19-21], some 
studies [22-23] pointed at the doctors as 
possible cause of failure because of their poor 
attitudes towards teamwork, their low 
involvement in the implementation process, 
their misunderstanding about medical benefits. 
The adoption of this service spans through 
innovation and overcoming the embedded 
conservatism of healthcare structure. Its 
implementation has a deep impact in changing 
the nature of current healthcare structures: 
hospital planners will need to reflect on a new 
organisational structure, designed to be 
flexible and to adapt to the driving force of 
each pathway. Therefore the healthcare 
structures could have a strategic perspective of 
management, focused on planning and 
managing the inter-dependencies between all 
the different types of assets and organisational 
units involved in the complex process outlined 
by care pathways.  
Although there is an increasing awareness 
of the importance of implementation of care 
pathways  in healthcare, there is little evidence 
of the organisational and management 
dimensions being understood and tackled in a 
systematic way, at micro (single organisational 
unit) or macro (trajectory of care between 
several units) level. Some experiences of 
development and implementation of pathway 
principles are ongoing in Italy, as showed 
below.  A typical example of clinical pathways 
is the “Day Service”, which simplifies and 
improves the performances of regional 
healthcare systems. The Day Service concerns 
complex, chronic clinical needs; it allows the 
effective management of medical 
examinations, instrumental and therapeutic 
interventions through a controlled number of 
accesses for patients who do not need 
continuous assistance from healthcare 
providers. The definition of a methodological 
path to design and introduce such innovation is 
proposed in the following framework, that 
takes into account both clinical aspects (such 
as appropriate care path) and organisational 
ones (such as process flow) Day Service is 
already available in other Italian regions, such 
as Emilia Romagna, Basilicata and Tuscany. 
Although they are based upon different 
premises, they all respond to the same need: 
shorten the time necessary for clinical and 
instrumental performances of critical diseases, 
such as the oncological and cardiovascular 
ones. Through the Day Service, the patient can 
obtain a diagnosis, restricting to one or few 
times the accesses to the structure and making 
all kind of health examinations within the 
same structure. On the other hand, Day 
Service allows the healthcare structure to 
avoid the duplication of unnecessary health 
examinations, to better schedule health 
examination, to give a more appropriate 
diagnosis. In Emilia Romagna, a one year 
experimental phase led to the definition of 
guidelines that were necessary to avoid useless 
and costly duplication of resources. Moreover, 
the experimental phase offered a number of 
markers to evaluate the impact of day service 
on the overall regional healthcare system. Two 
day services are currently available: 
departmental and multi-specialist, depending 
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on the complexity of the required activities. 
The introduction of a patient into the route 
depends upon a specialist, who also refers to 
the general practitioner with the final 
diagnosis, and only a limited number of 





Literature on strategic planning and some 
“ground rules” to improve integrated services, 
presented in a recent [24], guided the 
development of this methodological 
framework. These ground rules can be 
summarised in 4 steps:  
A. the definition of a target population; 
B. the definition of clinical pathways for 
each of the targeted care needs; 
C. the design of assets that are appropriate 
for those care processes; 
D. the determination of practical ways of 
moving from existing assets to those that are 
suited to the desired service delivery methods. 
 
Based on aforementioned references, the 
methodological approach to the design and to 
the introduction of a clinical pathway is 
underpinned on these assumptions:  
A. the innovative change must be driven by 
external forces (such as customers) and this 
implies an analysis of external environment; 
B. the innovative change must be integrated 
in organisational processes, and this concerns 
an analysis of the internal environment; 
C. the innovative change must be assessed 
through appropriate methods (such as 
cost/benefit ratios); 
D. the innovative change must start from 
the bottom-up, involving progressively 
physicians, paramedics, office workers and 
managers. 
Starting from these assumptions, the 
methodology framework is structured in three 
phases: external analysis, internal analysis, 
cost-benefit assessment.  
An external analysis of the care needs of 
the population occurs to implement and define 
the innovation to be introduced. Indeed, the 
design of the actual pathways focuses on 
diseases with a high death rate. 
Epidemiological studies, guidelines of 
National and European Healthcare Plan drive 
the choice of the target population, and help in 
the planning of the care trajectory. As well as 
any other innovation, the pathway has to 
integrate into organisational structures through 
a re-defining of process, behaviours and 
charges. Flowcharts tools, responsibility 
matrix, unstructured interviews support the 
analysis of the process “as is” and the planning 
of the process “to be”. Furthermore, an 
analysis of endowment of organization and of 
assets needs (such as infrastructure, adequate 
human resources and competences, 
information technology, equipment) allows the 
gaining of information about investments 
needed to implement the pathway. In order to 
overcome eventual cultural barriers of doctors 
and healthcare workers, who could cause the 
failure of innovation, and at the same time, to 
be more aware of organizational structures 
(activities carried out, work timetable, delivery 
timetable, shifts, and so on), all people 
working in the structure have to be involved in 
the design and introduction of innovation.  
The last phase concerns the benefit-cost 
analysis: the pathway must positively impact 
on social goals as well as on cost efficiency. 
The benefits depend upon the context 
(examples of benefits are the reduction of 
deaths, hospitalization, and of the escape 
index, with an increase of the appeal index), 
whereas the costs are the total costs of 
healthcare services foreseen in the pathway. 
According to benefit-cost analysis, the benefits 
have to be translated in monetary terms in 
order to be compared with costs.  
Figure 1 summarizes the steps of 
methodological framework.  
 
The methodological framework has been 
developed within the Department of Industrial 
Engineering (DII) and the Centre for 
Hypertension of Federico II University 
Hospital). The project is in the planning phase 
yet, accordingly the findings concern the 
external analysis. In particular, the external 
analysis allowed us to identify a clinical 
pathway, namely Complex and Coordinated 
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(PACC) for the prevention of cardiovascular 
diseases. 
The case study presented in this paper focuses 
on the introduction of a clinical governance 
tool in an organisational unit of the Federico II 
University Hospital. This clinical governance 
tool, namely PACC, is organized such as a 
Day Service and its implementation involves 
involves exclusively the organisational unit 
“Federico II University Centre for 
Hypertension”.  
The Federico II Centre for Hypertension 
The Federico II Centre for Hypertension 
belongs to the Department of Internal 
Medicine, Immunology and Cardiovascular 
Sciences. It started in 1980, and is actually 
among the National Centres of Excellence of 
the Italian Society of Hypertension. Its 
activities concern primary and secondary 
prevention of cardiovascular diseases, with a 
special focus on hypertension, whose 
occurrence among the western population 
peaks at 60-70 % for certain age groups. The 
Federico II Centre for Hypertension is based 
upon the highest levels of competence and 
efficiency, with driven and updated medical 
professionals. Moreover, it pioneers the novel 
frontiers of medicine, such as gene therapy and 
pharmacogenomics, and the evaluation of the 
early cardiovascular risk. The mission of the 
Centre is based upon the concept that 
cardiovascular diseases require the transfer of 
prevention activities from the excellence 
centres to the periphery, to assure the 
“capillarity” needed to their success. Therefore 
the centre experimented and implemented the 
use of Telemedicine, i.e. a controlled, 
telematics access to a database of clinical 
records for general physicians, and is inserted 
into a network of expertise such as 
interventional cardiology and radiology, 
endocrinology, nephrology, nuclear medicine, 
cardiac and vascular surgery [25]. The centre 
is conveniently connected with the Intensive 
Cardiac Care Unit (ICCU), offering well-timed 
access to hypertensive emergencies. The 
strong orientation of the Centre towards the 
continuous improvement, and its efforts to 
increase the appropriateness of diagnosis and 
care were conjugated with the awareness that 
instruments such as day-hospitals might not 
align with the aims of the current National and 
Regional Healthcare Plan. Therefore, its goal 
is the introduction of a Day Service to increase 
the prevention and reduce the progression of 
cardiovascular diseases, through the 
improvement of the clinical governance of the 
hypertensive patient.  
 
The external analysis: Complex and 
Coordinated Sanitary Package (PACC) as an 
instrument of clinical governance 
According to a number of epidemiological 
studies, there is a polarization of the most 
frequent causes of death in Italy, with the 
prevalence of cardiovascular diseases in the 
South, and cancer in the North. Among 
cardiovascular diseases, a pivotal role is 





Selection of benefit in terms of social, 
quality and cost goals  
Identification of costs of care 
scheduled for clinical pathways 
Identification of assets needed for the 
planned care processes (infrastructure, 
adequate human resources and 
competences, information technology, 
equipments) 
Design of processes to permit the 
integration of interconnected activities, 
defined in the pathway, with the existing 
ones. 
Selection of target population based 
on specific criteria (epidemiological, 
statistical, economical, social, previous 
experimental studies) 
Identification of care needs  
FIGURE 1 
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played by hypertension: the adequate control 
of hypertension by itself would significantly 
reduce the incidence of major, costly 
cardiovascular events and of heart failure. 
Therefore, the efficient prevention of 
hypertension becomes a critical priority of any 
western healthcare system. Primary prevention 
is strictly related to health promotion, as it 
implies distant and hopefully long lasting 
results. Screening for high blood pressure, 
personal habits and family history might be 
promoted with territory practitioners, taking 
advantage of the hypertension network, in 
order to identify subsets of individuals with a 
higher risk for cardiovascular diseases. 
Secondary prevention concerns a tighter 
control of selected populations in order to 
reduce the occurrence of acute cardiovascular 
events: a diagnostic route might be proposed, 
where the first step depends upon the careful 
examination of the hypertensive patient. The 
patient could be then introduced into a 
pathway of controls that are clinically 
appropriated and timely planned, in order to 
improve the compliance to therapy. An 
appropriate control of high blood pressure can 
be achieved only with careful medical 
controls, which should be properly scheduled 
depending upon the risk class of the patient, 
and after the achievement of therapeutic 
continuity. Waiting lists and the difficulty to 
manage complex diagnostic procedures 
undergo controls with a delay that poses them 
at risk for acute cardiovascular events. The 
cost of this situation has both a death toll and 
an impact in Disability Adjusted Life Years 
(DALYs), which rebound heavily upon the 
healthcare system. The introduction of the Day 
Service would allow the achievement of the 
aforementioned therapeutic goals, offering the 
patients the opportunity to enter a route 
enclosing the appropriate diagnostic 
instruments required by the physicians, 
organized in a single solution inside the 
Federico II Medical Centre. After the selection 
of target population, hypertensive patients, the 
identification of care needs occurs.  
The Centre for Hypertension designed a 
number of Complex and Coordinated Sanitary 
Packages (PACC), as appropriate diagnostic 
routes the patient could enter according to his 
needs and to the requirements of his physician. 
As the PACC defines a pathway to manage 
critical diseases, it can be considered a Day 
Service. Each single package was assembled 
according to the national and international 
hypertension guidelines (ESH – European 
Society of Hypertension – and ESC – 
European Society of Cardiology).  
The Centre for Hypertension identified 6 
PACCs: 3 for the initial screening and 3 for 
the follow-up. The 3 screening PACCs are 
named PS-1, PS-2, PS-3. Their aim is to 
investigate the “degree” of hypertension and 
assess the eventual organ damage. The 
physician will decide the adequate PS based 
on the first clinical evaluation. Usually, the 
three PS are independent but, depending upon 
the severity of hypertension, the physician can 
decide to combine them. Moving from PS-1 to 
PS-3, the set of diagnostic tools becomes more 
complex. 
Figure 2 shows diagnostic examinations 
included in PS-1, PS-2 and PS-3. 
The 3 follow-up PACs, named PF-1, PF-
2, PF-3, are aimed to monitor the efficacy of 
the therapy, and the evolution of the disease. 
The attribution of patients to one of the 3 PFs 
depends upon the degree of hypertension that 
has been identified during the screening phase. 
Depending upon the contemporary presence of 
the pathological conditions, hypertensive 
patients can be defined hypertensive, or 
diabetic hypertensive, or ischemic 
hypertensive – respectively associated to PF-1, 
PF-2, and PF-3. Furthermore, the patients are 
attributed to five categories related to degree 
of risk  (the risk degree refers to the 
probability to develop an acute cardiovascular 
event):  
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very high risk, high risk, moderate risk, low 
risk, average risk.  Finally, the central aim of 
PACCs is the achievement of the clinical 
governance of hypertensive patients by means 
of a fast, flexible, appropriate (both clinically 
and economically) and efficient diagnostic and 
follow-up tool.  
 
The internal analysis: the design of 
processes at the Federico II Centre for 
Hypertension  
In order to implement the PACCs,  
the analysis of assets needs and the re-design 
of organizational and productive processes are 
needed. As the present research is in the first 
stages, the internal analysis focused only on a 
mapping of actual processes and activities of 
the Centre for Hypertension. The services 
offered by the Centre for Hypertension are the 
followings: 
Figure 2: Diagnostic pathways for hypertensive patient stadiation 
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- Cardiac ultrasound 
- Cardiac ultrasound following 
pharmacological stress 
- Renal arteries ultrasound 
- Carotid ultrasound 
- Stress EKG 
- Follow-up post-myocardial infarction 
(MI)  
- Emergency follow-up 
- 24h EKG monitoring 
- 24h Blood pressure monitoring 
- First screening examination  
 
In order to re-design the processes, the 
actual patients’ route (macro-process) has been 
mapped, since they enter the Federico II 
Medical Centre, through the reservation of the 
medical service, up to their enrolment into the 
follow-up (figure 4). 
The input and the output of the macro-
process “patients’ route” is the patient. Inside 
the macro-process, 4 sub-processes are 
identified: 
Critical flows 
Figure 3: Diagnostic pathways for 
multimorbid hypertensive patients  
Translational Medicine @ UniSa - ISSN 2239-9747 2014, 8(2): 7-17 
 
 Università degli Studi di Salerno  14 
1. Booking, including all activities related 
to the application, change or cancellation of 
the booking for a medical examination;  
2. Medical examination, concerning all 
activities related with the actual outpatient 
examination; 
3. Activities that are external to the 
Centre for Hypertension but available 
inside the Federico II hospital, following 
hospital admittance either in day hospital, or 
with regular hospitalization; 
4. Activities external to the Federico II 
hospital, not performed inside the Federico II 
hospital.  
As showed by the mapping in figure 4, the 
processes of the Federico II Centre for 
Hypertension are strictly interconnected with 
the context of the Federico II University 
Hospital: a patient enters the hospital to access 
the Centre, but he can also access the Centre 
starting from a regular hospitalization in the 
Federico II University Hospital.   
The map of the processes underlines some 
critical flows. The flow “D” is represented by 
patients who, after the booking of the visit at 
Centre for Hypertension Federico II, don’t 
make the visit due to several reasons, such as 
too long waiting lists causing organisational 
bottlenecks. The flow “I” is represented by 
patients who undergo the examinations at 
other healthcare structures and, eventually, 
come back to the Centre only for the specialist 
visit. This event causes loss of gain for the 
Federico II University Hospital. The flow “L” 
is similar to the flow “I” but it concerns 
hospitalized patients. Lastly, the flow “N” 
concerns patients who don’t came back to the 
Centre after the first visit.  The critical reason 
of this escape could be the long time between 
the first examination and the second, 
apparently due to the instrumental exams 
required by the cardiologists, to be carried out 
outside the Centre for Hypertension. 
The implementation of PACCs could 
overcome these criticalities. A well-designed 
clinical pathway would decrease the waiting 
lists and, furthermore, it might localize the 
most part of the requested examinations at the 
Centre for Hypertension, consequently 
reducing the escapes towards other structures. 
Of course, a deeper analysis of each of four 
processes is necessary to re-design the macro-
process in order to integrate the PACCs into 
the actual activity of Federico II Centre for 
Hypertension. This analysis is one of the 
activities that we are developing at the 
Federico II Centre for Hypertension. 
 
III. RESULTS 
To achieve effective clinical governance, 
economical awareness is crucial: this 
consideration prompted us to evaluate the 
convenience of the PACCs through a cost-
benefit analysis. In this phase of research, we 
have only defined the benefits: we identified 
the benefits with respect to the Regional 








FEDERICO II HOSPITAL 
EXTERNAL ACTIVITIES  
OUTSIDE 















 Figure 4: LEGEND 
A= External Patients Booking  
B= Emergency Patients (118) 
C= Patients Undergoing Examination 
D= Patients Cancelling Booking 
E= Patients Afferent To General Practitioner 
F= Follow-Up Post-Admission  
G= Patients Admitted Post-Examination 
H= Booking Post Admission  
I= Patients Leaving The Hospital After Examination 
L= Patients Leaving The Hospital After Admission 
M= Patients Booking Follow-Up After Instrumental 
Procedures Outside 
N= Patients Deciding Not To Come Back 
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Healthcare System and the benefits with 
respect to the Federico II University Hospital. 
From the point of view of Campania 
Region, the benefits, grouped in 4 classes, are:  
- B1, that takes in account the death 
reduction;  
- B2, that concerns the hospitalization 
reduction;  
- B3 that refers to the escape rate 
reduction (percentage of patients going to 
healthcare structures located in other Italian 
regions or in different countries);  
- B4, the gain due to the appeal rate 
increase (number of patients coming to 
healthcare structures situated in the 
considered region).  
On the contrary, from the point of view of 
the Federico II University Hospital, the 
benefits concern above all the gain obtained 
from diagnostic examinations. In fact, the 
patients following a pathway will do all the 
examinations at the Centre for the 
Hypertension and not at any other structures. 
These benefits, accordingly the gains, have to 
be spread among the healthcare services 
offered by Centre. These healthcare services 
are: specialists’ activity, Day Hospital activity, 
ordinary hospitalisation.  
So we identified 3 classes of benefits:  
- B1 which expresses the gain for 
specialists’ activity; 
- B2 the gain for Day Hospital activities;  
- B3 the gain for the hospitalisation 
activities.  
With reference to costs, the lack of an 
accounting system at Federico II University 
Hospital made it very difficult to gather the 
data needed to compute them. The only 
information available is now the cost of each 
diagnostic examination based on DRGs 
(Diagnosis Related Groups) table. DRGs are 
fixed by National Healthcare System. In this 
way, we can’t underpin the real cost of each 
PACCs for the Centre.  
Further developments of this research will 
concern the application of Activity-Based 
Costing to calculate the real costs of PACCs, 
taking into account the new organizational 





The Healthcare Systems are focusing on a new 
way to manage and promote health: the 
clinical pathway, an integrated disease 
“management” tool. The pathway outlines that 
the new mission of a modern Healthcare 
System is not limited to cure diseases, but is 
committed to efficiently handle and prevent 
them. As discussed in the introduction, several 
studies discuss the clinical implications (how 
each specific pathway can impact positively on 
some critical aspects of care, such as cost, 
quality and patient outcomes), but very few 
studies focus on the organisational 
implications (how the pathway can be 
integrated into the actual activities of a 
healthcare structure). The present paper 
contributes to this issue by presenting a 
methodological framework to manage the 
design and the implementation of a clinical 
pathway: both clinical and organisational 
aspects are taken into account. 
The methodological framework has been 
structured into 3 phases: an analysis of the 
external environment, an analysis of the 
internal context and a benefit-cost assessment. 
Since  the presented research, involving the 
Department of Industrial Engineering (DII) 
and Federico II Centre for Hypertension, is 
still in a planning phase, our findings concern 
above all the external analysis: the description 
of a specific pathway to manage hypertension, 
and therefore prevent cardiovascular diseases. 
This pathway, is delivered under the PACC, a 
new health care covered service that the 
Federico II Centre for Hypertension is 
planning to implement in its organisation.  
To a small extent other results can be 
observed. First of all, the case study shows that 
the introduction of a similar service impacts on 
the organisation of the structure. An analysis 
of organizational processes “as are” and the re-
design of processes “to be” are necessary to 
integrate the clinical pathway into the actual 
activities. We only presented a map of all 
processes of the Centre “as are” and their 
critical flows. But a deeper analysis of each 
process, concerning its activities, the human 
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resources involved, the responsibilities 
requested and the needed changes will occur. 
An analysis of required investments to the 
implementation of PACCs would be necessary 
as well. To carry out the benefit-cost analysis, 
a new accounting approach has to be 
developed. The Federico II University 
Hospital should introduce a Management 
Accounting System based on process logic. 
Finally, the implementation of similar 
innovations, that impact both on clinical and 
organizational aspects, requires the 
intervention of multidisciplinary teams, 
integrating cardiologists and health care 
managers.  
Further development of this research 
concerns the internal analysis, in particular the 
planning of organizational processes “to be” 
and the investments assessment. With respect 
to benefit-cost analysis, the lack of an 
accounting system at Federico II University 
Hospital could hinder the computation of 
benefits and costs. However, very preliminary 
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